Share

Search your stocks

Ctrl+K

Asston Pharmaceuticals Ltd.Asston Pharmaceuticals Ltd.

95(-3.06%)

1W: +1.55%

1M: -7.76%

1Y: -

Asston Pharmaceuticals Quarterly Results

Pros & Cons

POSITIVES

Consistent revenue growth observed over the last four quarters, indicating strong market demand.
Improved profit margins in the latest quarter suggest better cost management strategies.
Increased investments in R&D have led to a diversified product pipeline, enhancing future growth potential.

NEGATIVES

Declining net profit in the latest quarter raises concerns about operational efficiency.
Rising raw material costs have negatively impacted the gross margin compared to previous quarters.
Increased competition in the manufacturing sector is putting pressure on market share and pricing strategies.

Quarterly Results Data (Numbers are in Crore)

Field	Trend
Expenses	-
Operating Profit	-
Other Income	-
Tax	-